CARULLO, MARTINA
 Distribuzione geografica
Continente #
EU - Europa 92
NA - Nord America 69
AS - Asia 45
AF - Africa 16
Totale 222
Nazione #
IT - Italia 73
US - Stati Uniti d'America 69
SG - Singapore 34
CI - Costa d'Avorio 9
SE - Svezia 8
CN - Cina 7
SN - Senegal 7
PL - Polonia 5
IN - India 4
AT - Austria 3
DE - Germania 2
FI - Finlandia 1
Totale 222
Città #
New York 16
Pisa 15
Florence 11
Abidjan 9
Ashburn 8
Singapore 8
Dakar 7
Genoa 6
Milan 6
Ogden 5
Warsaw 5
Hyderabad 4
Los Angeles 4
Salerno 4
Turin 3
Vienna 3
Castelvetro di Modena 2
Castiglione Chiavarese 2
Center 2
Fano 2
Phoenix 2
Shanghai 2
Taranto 2
Washington 2
York 2
Billings 1
Boardman 1
Cologne 1
Gargallo 1
Kent 1
Montereale Valcellina 1
Rome 1
Vicopisano 1
Totale 140
Nome #
Primary tumour side as a driver for treatment choice in RAS wild-type metastatic colorectal cancer patients: a systematic review and pooled analysis of randomised trials 32
Circulating Tumor DNA as a Marker of Minimal Residual Disease After Radical Resection of Colorectal Liver Metastases 31
Benefit from upfront FOLFOXIRI and bevacizumab in BRAFV600E-mutated metastatic colorectal cancer patients: does primary tumour location matter? 25
Surgery combined with intra-operative microwaves ablation for the management of colorectal cancer liver metastasis: A case-matched analysis and evaluation of recurrences 25
Total neoadjuvant treatment and organ preservation strategies in the management of localized rectal cancer: A narrative review and evidence-based algorithm 24
Bone metastases are associated with worse prognosis in patients affected by metastatic colorectal cancer treated with doublet or triplet chemotherapy plus bevacizumab: a subanalysis of the TRIBE and TRIBE2 trials 20
The prognostic value of radiomic features in liver-limited metastatic colorectal cancer patients from the TRIBE2 study 20
Immune-Checkpoint Inhibitors (ICIs) in Metastatic Colorectal Cancer (mCRC) Patients beyond Microsatellite Instability 20
Adverse events during first-line treatments for mCRC: The Toxicity over Time (ToxT) analysis of three randomised trials 16
null 15
The Evolving Landscape of Immunotherapy in Locally Advanced Rectal Cancer Patients 14
Molecular screening with liquid biopsy for anti-EGFR retreatment in metastatic colorectal cancer: preliminary data from the randomized phase 2 PARERE trial 5
Primary Tumor Resection in Synchronous Metastatic Colorectal Cancer Patients Treated with Upfront Chemotherapy plus Bevacizumab: A Pooled Analysis of TRIBE and TRIBE2 Studies 4
ShorTrip Trial: A Prospective, Multicentric Phase II Single-Arm Trial of Short-Course Radiotherapy Followed by Intensified Consolidation Chemotherapy With the Triplet FOLFOXIRI as Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer 3
Treatment of patients with BRAFV600E-mutated metastatic colorectal cancer after progression to encorafenib and cetuximab: data from a real-world nationwide dataset 2
Totale 256
Categoria #
all - tutte 1.268
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.268


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202352 0 0 0 0 0 15 0 2 22 0 12 1
2023/2024186 6 10 18 9 19 24 26 4 12 13 24 21
2024/202518 18 0 0 0 0 0 0 0 0 0 0 0
Totale 256